Objective-To investigate the occurrence of cervical intraepithelial neoplasia in women with glomerulonephritis and its possible association with immunosuppressive treatment.
Introduction
Immunosuppressive treatment is associated with an increased risk of cancer.' Renal transplant patients are no exception. Immunosuppressive treatment is also associated with an increased risk of virus infection,' including infection with human papillomavirus.4 As this virus is implicated in the pathogenesis of cervical intraepithelial neoplasia59 recent reports of an increase in the incidence of this disease in renal transplant recipients receiving immunosuppressive treatment were to be expected, particularly as this increase has been related to human papillomavirus type 16/18.10 The association between immunosuppression and cervical intraepithelial neoplasia is thus well reported and generally accepted.
Our attention was drawn to a small group of women with glomerulonephritis and cervical intraepithelial neoplasia, not all of whom had received immunosuppressive treatment. We studied a series of women with glomerulonephritis, from whom cervical cytological or histological specimens were also available, to investigate the possibility of a primary relation between glomerulonephritis and cervical intraepithelial neoplasia, independent of immunosuppressive treatment.
Methods
Our department serves the county of Hordaland and its surrounding area, receiving roughly 40 000 gynaecological cytological specimens and 23000 surgical biopsy specimens each year. Over the study period glomerulonephritis was diagnosed in biopsy specimens from 81 women, from whom routine gynaecological cytological or histological specimens (or both) were also available. These women formed our study group. They were born from 1921 to 1970.
We established a case and age matched control group of 162 women. For each case we found the next two women born in the same year from whom a routine gynaecological cytological specimen had been received at the same time as the corresponding first specimen for the index case. For the youngest woman, who was born in 1970, there was an age difference of three and four years between her and her controls; for one woman, born in 1921, there was an age difference of five years with one of the controls. Otherwise, both controls were born in the same year as their index case. None of the controls had glomerulonephritis or any other lesion associated with immunosuppressive treatment.
We recorded the age of the woman when glomerulonephritis was diagnosed. The kidney biopsy specimens were reviewed. The type of kidney lesion and its immunological characteristics were recorded. These had been investigated at primary diagnosis either by immunofluorescence techniques on frozen sections or in later cases using a standard peroxidaseantiperoxidase technique on formalin fixed material.
We also recorded the use of immunosuppressive treatment, its type, duration, and the reason for its prescription.
We recorded the woman's age when cervical intraepithelial neoplasia was first diagnosed. All cytological or histological specimens from these women were reviewed for the presence or absence of koilocytosis." When sufficient material was available these specimens were also tested for human papillomavirus types Cervical lesions-There were more cases of cervical intraepithelial neoplasia in the study group: 16/81 (20%) of the women had cervical intraepithelial neoplasia in the study group compared with 7/162 (4%) of the control group (table II) . This fivefold difference was significant (x2=13, p<0-001). There were more severe lesions in the study group than in the control group (table III) . The total numbers were low, but there was only one woman with grade III disease among the 162 controls (1%) compared with' nine (11%) in the study group-that is, an 18-fold difference.
Immunosuppressive treatment- Table IV shows that immunosuppressive treatment had been given to 19 (23%) of the 81 women with glomerulonephritis. In five of them cervical intraepithelial neoplasia was subsequently diagnosed. Cervical intraepithelial neoplasia was also diagnosed in 9 of the 62 (15%) who had not received immunosuppressive treatment. This difference was not significant (x2=O 7, p<02). There was great variation in the age at which the 16 women with glomerulonephritis had cervical intraepithelial neoplasia diagnosed (figure). The figure shows the course of the disease in each woman, starting with the youngest at the top. She had received immunosuppressive treatment (for systemic lupus erythematosus) before presenting with her kidney lesion. This was followed after three years by the cervical lesion. The next woman presented first with cervical intraepithelial neoplasia, developing glomerulonephritis 12 years later. In summary, the diagnosis of glomerulonephritis preceded that of cervical intraepithelial neoplasia in six women, was made in the same year in one, and came after cervical intraepithelial neoplasia in nine. The interval between the two diagnoses tended to be longer when cervical intraepithelial neoplasia was diagnosed first. Cervical intraepithelial neoplasia occurred in nine of the 16 women with glomerulonephritis who had not received immunosuppressive treatment. When this was used (in seven women) it preceded the diagnosis of glomerulonephritis in four (all with systemic lupus erythematosus), was given on diagnosis in two, and after in one.
Cross checking of the results showed that five of the BMJ VOLUME 302 16 and in normal tissue adjacent to such lesions.'7 Its association with cervical lesions in immunosuppressed patients is well established.40 1819 Our results show that glomerulonephritis and cervical intraepithelial neoplasia may parallel. The renal lesion may present either before or after cervical intraepithelial neoplasia. The cervical intraepithelial neoplasia was of viral origin in most of our cases tested. The presence ofmore than one human papillomavirus type was common, including both 6/11 and 16/18. In addition, the 81 women with glomerulonephritis had a significantly higher incidence of cervical intraepithelial neoplasia and a greater degree of cervical koilocytosis than those of case matched controls. Virus infection, in particular human papillomavirus infection, is a well known complication of immunosuppressive treatment.9 In keeping with this the cervical lesion developing in women with glomerulonephritis receiving immunosuppressive treatment was more advanced at diagnosis than that in untreated women. Not all of the women with glomerulonephritis who received immunosuppressive treatment showed cervical intraepithelial neoplasia, however, and some had cervical intraepithelial neoplasia without immunosuppression. Furthermore, there was no significant difference in the incidence of cervical intraepithelial neoplasia between those who received and those who did not receive immunosuppressive treatment. Thus there seems to be a primary relation between glomerulonephritis and cervical intraepithelial neoplasia. This may be related to the virus association found in cervical intraepithelial neoplasia. On the basis of our findings cervical intraepithelial neoplasia in women with glomerulonephritis should not be regarded as merely an iatrogenic lesion. All such women should have routine cervical smears, irrespective of their use of immunosuppressive treatment.
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